Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > HLVX HilleVax > Company Profile
HLVX HilleVax
13.010
+1.160+9.79%
Symbol
HLVX
Company Name
HilleVax, Inc.
Listing Date
04/29/2022
Establishment Date
-
CEO
Hershberg M.D., Ph.D., Robert M.
Market
NASDAQ
Employees
31
Securities Type
Ordinary Shares
Fiscal Year Ends
December 31
Address
75 State Street,Suite 100
City
Boston
Province
Massachusetts
Country
United States of America
Zip code
02109
Phone
1-617-213-5054
Profile
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Company Overview
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
CEO: Hershberg M.D., Ph.D., Robert M.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top